PharmacoEconomics Journal Issues Research Articles in Vol. 42, Issue 2
February 29, 2024
February 29, 2024
BASEL, Switzerland, Feb. 29 -- PharmacoEconomics, a peer-reviewed journal that says it features application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes, published research articles on the following topics in its February 2024 edition (Vol. 42, Issue 2):
* Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer: Ev . . .
* Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer: Ev . . .